Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
RMD Open|June 15, 2023
Analysis of serum proteomics data identifies a quantitative association between beta-defensin 2 at baseline and clinical response to IL-17 blockade in psoriatic arthritisMathias Cardner, Danny Tuckwell, Anna Kostikova, et al.Paediatric Drugs|June 13, 2022
Efficacy of Secukinumab Across Subgroups and Overall Safety in Pediatric Patients with Moderate to Severe Plaque Psoriasis: Week 52 Results from a Phase III Randomized StudyNina Magnolo, Külli Kingo, Vivian Laquer, et al.Journal of the American Academy of Dermatology|September 23, 2021
A phase 3 open-label, randomized multicenter study to evaluate efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis: 24-week resultsNina Magnolo, Külli Kingo, Vivian Laquer, et al.Frontiers in Immunology|October 15, 2024
Unveiling signaling pathways inducing MHC class II expression in neutrophilsPascal Forrer, Darya Palianina, Claudia Stühler, et al.Nature Microbiology|January 24, 2017
Myeloperoxidase targets oxidative host attacks to Salmonella and prevents collateral tissue damageNura Schürmann, Pascal Forrer, Olivier Casse, et al.The Journal of Infectious Diseases|March 10, 2015
Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation and Association With Occurrence and Outcome of Invasive AspergillosisClaudia Stuehler, Esther Kuenzli, Veronika K Jaeger, et al.American Journal of Clinical Dermatology|June 21, 2023
Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical TrialsMichael Sticherling, Arjen F Nikkels, Ashraf M Hamza, et al.Pageof 1